Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Macrogol, Kombinationen (ATC-Code: A06AD65).
AOK Niedersachsen. Die Gesundheitskasse.
The work
Conclusion of a non-exclusive discount agreement for Macrogol combination drugs (ATC A06AD65) with AOK Niedersachsen from 01.05.2025 to 30.04.2027.
- Must be a pharmaceutical entrepreneur under § 4 Abs. 18 AMG.
- Agreement is non-exclusive and part of an 'open-house model'.
- Contract duration is a maximum of 24 months, ending no later than 30.04.2027.
Key facts
- Contract period
- Up to 24 months, starting from 01.05.2025 and ending no later than 30.04.2027.
- Evaluation
- This is a contract conclusion process, not a traditional tender evaluation.
What it takes to qualify
Worth a closer look
- The text states this is not a public procurement in the sense of Directive 2014/24/EU, but a publication for transparency.
- The exact submission address is 'in den Vertragsunterlagen genannten Adresse' (the address mentioned in the contract documents).
Experience
- At least 1 similar work — Pharmazeutischer Unternehmer i. S. d. § 4 Abs. 18 AMG
- Experience as a pharmaceutical entrepreneur under German law (AMG)
Certifications and registrations
Pharmazeutischer Unternehmer i. S. d. § 4 Abs. 18 AMGMust be a pharmaceutical entrepreneur as defined by German law.
GST registration (optional)Not mentioned in the provided text.
PAN registration (optional)Not mentioned in the provided text.
EPF registration (optional)Not mentioned in the provided text.
ESIC registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- VertragsunterlagenContract documents to be submitted for the agreement.
- VertragsbedingungenContract conditions to be submitted for the agreement.